CVE detail

CVE-2025-36226 — CVE-2025-36226

Published 2026-03-10 · Modified 2026-06-17 · Vendor ibm · Product aspera_faspex · Source nvd

MEDIUM

severity

CVSS-derived band

5.4

CVSS v3

0–10 scale

0.0021

EPSS probability

exploitation probability, 30d

11.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.